Delee

Early Stage

Blood testing device for early diagnosis of cancer and treatment monitoring

Analytics

Raised to Date: Raised: $118,807

Aggregate Commitments $

Platform

StartEngine

Start Date

09/08/2021

Close Date

03/07/2022

Min. Goal

$10,000

Max. Goal

$4,999,998

Min. Investment

$199

Security Type

Equity - Preferred

Funding Type

RegCF

Series

Seed

Pre-Money Valuation

$22,040,057

Rolling Commitments $

Status

Active

Reporting Date

09/19/2021

Days Remaining

169

% of Min. Goal

1,188%

% of Max. Goal

2%

Likelihood of Max
unlikely
Avg. Daily Raise

$10,801

Momentum
cool
Log in or create a free account today to gain access to KingsCrowd analytics.
Location

Laredo, Texas

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Distribution Model

B2B

Margin

Medium

Capital Intensity

High

Business Type

Growth

Delee, with a valuation of $22 million, is raising funds on StartEngine. The company has created a device, CytoCatch, for the early detection of circulating tumor cells in the bloodstream. The device also assists in the personalization and optimization of the treatment of patients and monitor the effectiveness of treatments. Thus, CytoCatch helps to increase the chances of curing cancer and survival. Delee already has a fully functional technology that is being tested for prostate cancer. Delee was founded by Liza Velarde, Juan Felipe Yee, and Alejandro Abarca in November 2016. The current crowdfunding campaign has a minimum target of $9,999.84 and a maximum target of $4,999,998.02. The campaign proceeds will be used for the commercial launch of the technology and beginning the process to get FDA clearance for the commercialization of the technology.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$55,613

COGS

$0

$1,454

Tax

$0

$0

 

 

Net Income

$-622,364

$-91,803

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$344,289

$1,594

Accounts Receivable

$98,848

$43,156

Total Assets

$907,032

$418,377

Short-Term Debt

$9,896

$23,128

Long-Term Debt

$0

$0

Total Liabilities

$9,896

$23,128

Financials as of: 09/08/2021
Log in or create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Delee 03/07/2022 StartEngine $22,040,057 $118,807 Equity - Preferred Active RegCF
Delee 04/24/2020 Republic $10,000,000 $1,070,000 SAFE Funded RegCF
Log in or create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Starter

$8.33 /month
billed annually
Free portfolio tracking. Limited reports and filters.
Plan Includes:
Everything in Free, plus
Advanced company search ( limited filters)
Founder profiles and exclusive webinars
2 Analyst Reports per month
Get Starter Annual

Pro

$25 /month
billed annually
Unlimited analyst reports and market analytics.
Plan Includes:
Everything in Starter, plus
Full access to all Analyst Reports
Filter on Staff Picks (e.g. Top Deal, Deal to Watch, etc.)
Market Analytics
Get Pro Annual

Merlin

$41.67 /month
billed annually
Full site access including Merlin ratings.
Plan Includes:
Everything in Pro, plus
Search and filter companies by Merlin ratings
Company specific Merlin rating and risk assessment
Get Merlin Annual
Already a member? Log in here.

Ratings

Analyst Report

Other Deals

Covira Surgical on StartEngine 2021

The biotech company is focused on novel therapeutic alternatives to reduce post-surgical infections. The procedures of Covira Surgical leverage the…

Valuation: $9,987,500
Min Investment: $250
Industry: Healthcare & Pharmaceuticals
Raised $185,816 of $1,070,000 max
RegCF

Fluo Labs on StartEngine 2021

The medical device of Fluo Labs uses light therapy to relieve patients of their allergy symptoms without the use of…

Valuation: $12,000,000
Min Investment: $250
Industry: Healthcare & Pharmaceuticals
Raised $85,021 of $3,800,000 max
RegCF

Actipulse Neuroscience on Republic 2021

The business also aims to bring non-invasive treatment to patients’ homes. Adrien Chatillon founded Actipulse Neuroscience in June 2019. The…

Valuation Cap: $10,000,000
Min Investment: $100
Industry: Healthcare & Pharmaceuticals
Raised $92,426 of $1,070,000 max
RegCF

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Add Delee on StartEngine 2021

Follow company

Follow Delee on StartEngine 2021